Literature DB >> 28375448

Alginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysis.

D A Leiman1, B P Riff2, S Morgan3, D C Metz4, G W Falk4, B French3,5,6,7, C A Umscheid3,5,6,7,8, J D Lewis4,5,6,7.   

Abstract

In patients with gastroesophageal reflux disease (GERD) and erosive esophagitis, treatment with proton pump inhibitors (PPIs) is highly effective. However, in some patients, especially those with nonerosive reflux disease or atypical GERD symptoms, acid-suppressive therapy with PPIs is not as successful. Alginates are medications that work through an alternative mechanism by displacing the postprandial gastric acid pocket. This study performed a systematic review and meta-analysis to examine the benefit of alginate-containing compounds in the treatment of patients with symptoms of GERD. PubMed/MEDLINE, Embase, and the Cochrane library electronic databases were searched through October 2015 for randomized controlled trials comparing alginate-containing compounds to placebo, antacids, histamine-2 receptor antagonists (H2RAs), or PPIs for the treatment of GERD symptoms. Additional studies were identified through a bibliography review. Non-English studies and those with pediatric patients were excluded. Meta-analyses were performed using random-effect models to calculate odds ratios (OR). Heterogeneity between studies was estimated using the I2 statistic. Analyses were stratified by type of comparator. The search strategy yielded 665 studies and 15 (2.3%) met inclusion criteria. Fourteen were included in the meta-analysis (N = 2095 subjects). Alginate-based therapies increased the odds of resolution of GERD symptoms when compared to placebo or antacids (OR: 4.42; 95% CI 2.45-7.97) with a moderate degree of heterogeneity between studies (I2 = 71%, P = .001). Compared to PPIs or H2RAs, alginates appear less effective but the pooled estimate was not statistically significant (OR: 0.58; 95% CI 0.27-1.22). Alginates are more effective than placebo or antacids for treating GERD symptoms. © International Society for Diseases of the Esophagus 2017. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  alginate; gastroesophageal reflux disease; meta-analysis

Mesh:

Substances:

Year:  2017        PMID: 28375448      PMCID: PMC6036656          DOI: 10.1093/dote/dow020

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  32 in total

1.  A comparison between sodium alginate and magaldrate anhydrous in the treatment of patients with gastroesophageal reflux symptoms.

Authors:  Edoardo G Giannini; Patrizia Zentilin; Pietro Dulbecco; Elena Iiritano; Claudio Bilardi; Edoardo Savarino; Carlo Mansi; Vincenzo Savarino
Journal:  Dig Dis Sci       Date:  2006-09-15       Impact factor: 3.199

2.  Comparative study of Algicon suspension and magnesium trisilicate mixture in the treatment of reflux dyspepsia of pregnancy.

Authors:  G D Lang; A Dougall
Journal:  Br J Clin Pract Suppl       Date:  1989-02

Review 3.  Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.

Authors:  B van Pinxteren; M E Numans; P A Bonis; J Lau
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

Review 4.  Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review.

Authors:  Hashem B El-Serag; Stephen Sweet; Christopher C Winchester; John Dent
Journal:  Gut       Date:  2013-07-13       Impact factor: 23.059

5.  First line treatment with omeprazole provides an effective and superior alternative strategy in the management of dyspepsia compared to antacid/alginate liquid: a multicentre study in general practice.

Authors:  J Goves; J K Oldring; D Kerr; R G Dallara; E J Roffe; J A Powell; M D Taylor
Journal:  Aliment Pharmacol Ther       Date:  1998-02       Impact factor: 8.171

6.  Randomized, multicentre comparison of sodium alginate and cisapride in the symptomatic treatment of uncomplicated gastro-oesophageal reflux.

Authors:  T Poynard; B Vernisse; H Agostini
Journal:  Aliment Pharmacol Ther       Date:  1998-02       Impact factor: 8.171

Review 7.  Proton pump inhibitor failure--what are the therapeutic options?

Authors:  Ronnie Fass
Journal:  Am J Gastroenterol       Date:  2009-03       Impact factor: 10.864

Review 8.  Overutilization of proton pump inhibitors: a review of cost-effectiveness and risk [corrected].

Authors:  Joel J Heidelbaugh; Kathleen L Goldberg; John M Inadomi
Journal:  Am J Gastroenterol       Date:  2009-03       Impact factor: 10.864

9.  Clinical and laboratory studies of the antacid and raft-forming properties of Rennie alginate suspension.

Authors:  G N Tytgat; G Simoneau
Journal:  Aliment Pharmacol Ther       Date:  2006-03-15       Impact factor: 8.171

10.  Gaviscon® vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial.

Authors:  Denis Pouchain; Marc-André Bigard; François Liard; Marc Childs; Annick Decaudin; Donna McVey
Journal:  BMC Gastroenterol       Date:  2012-02-23       Impact factor: 3.067

View more
  12 in total

1.  Alginates: From the ocean to gastroesophageal reflux disease treatment.

Authors:  Serhat Bor; İsmail Hakkı Kalkan; Altay Çelebi; Dinç Dinçer; Filiz Akyüz; Peter Dettmar; Hasan Özen
Journal:  Turk J Gastroenterol       Date:  2019-09       Impact factor: 1.852

Review 2.  Medical Treatment of Gastroesophageal Reflux Disease.

Authors:  Daniel A Kroch; Ryan D Madanick
Journal:  World J Surg       Date:  2017-07       Impact factor: 3.352

Review 3.  Management of upper gastrointestinal symptoms in patients with autoimmune gastritis.

Authors:  Juan D Gomez Cifuentes; Jordan Sparkman; David Y Graham
Journal:  Curr Opin Gastroenterol       Date:  2022-09-09       Impact factor: 2.741

4.  Barrier Effect of a New Topical Agent on Damaged Esophageal Mucosa: Experimental Study on an ex vivo Swine Model.

Authors:  Roberta Salaroli; Domenico Ventrella; Chiara Bernardini; Alberto Elmi; Augusta Zannoni; Maria Laura Bacci; Monica Forni; Fiorella Calanni; Antonella Ferrieri; Fabio Baldi
Journal:  Clin Exp Gastroenterol       Date:  2020-11-13

Review 5.  Strategies for Effective Discontinuation of Proton Pump Inhibitors.

Authors:  Judith Kim; John W Blackett; Daniela Jodorkovsky
Journal:  Curr Gastroenterol Rep       Date:  2018-05-16

6.  The Spectrum of Reflux Phenotypes.

Authors:  Lisa B Mahoney; Rachel Rosen
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-12

Review 7.  Phycochemical Constituents and Biological Activities of Fucus spp.

Authors:  Marcelo D Catarino; Artur M S Silva; Susana M Cardoso
Journal:  Mar Drugs       Date:  2018-07-27       Impact factor: 5.118

8.  Label-free multiphoton microscopy reveals relevant tissue changes induced by alginate hydrogel implantation in rat spinal cord injury.

Authors:  Roberta Galli; Kerim H Sitoci-Ficici; Ortrud Uckermann; Robert Later; Magda Marečková; Maria Koch; Elke Leipnitz; Gabriele Schackert; Edmund Koch; Michael Gelinsky; Gerald Steiner; Matthias Kirsch
Journal:  Sci Rep       Date:  2018-07-18       Impact factor: 4.379

Review 9.  Management of gastroesophageal reflux disease in adults: a pharmacist's perspective.

Authors:  Brett MacFarlane
Journal:  Integr Pharm Res Pract       Date:  2018-06-05

10.  The Effect of Alginate in Gastroesophageal Reflux in Infants.

Authors:  Silvia Salvatore; Antonio Ripepi; Koen Huysentruyt; Kristel van de Maele; Luana Nosetti; Massimo Agosti; Alessandro Salvatoni; Yvan Vandenplas
Journal:  Paediatr Drugs       Date:  2018-12       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.